Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Neurology | Psychiatry/Psychology | Family Medicine
Attention Deficit/Hyperactivity Disorder (ADHD - Adults) Clinical Trials
A listing of Attention Deficit/Hyperactivity Disorder (ADHD - Adults) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 5 6 Last
Alabama
Nelson Handal
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Arizona
Melmed Center
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Wen Cal
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Arkansas
Clinical Study Centers, LLC
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Clinical Study Centers, LLC
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
California
Pharmacology Research Institute, Encino
This is a Phase 2 Randomized, Double-Blind, Parallel-Group, Multicenter Efficacy and Safety Study of SEP-225289 versus Placebo in Adults with Attention Deficit Hyperactivity Disorder (ADHD)
Pharmacology Research Institute, Los Alamitos
This is a Phase 2 Randomized, Double-blind, Parallel-Group, Multicenter Efficacy and Safety Study of SEP-225289 versus Placebo in Adults with Attention Deficit Hyperactivity Disorder (ADHD)
Pharmacology Research Institute, Newport Beach
This is a Phase 2 Randomized, Double-blind, Parallel-Group, Multicenter Efficacy and Safety Study of SEP-225289 versus Placebo in Adults with Attention Deficit Hyperactivity Disorder (ADHD)
Elite Clinical Trials, Inc.
Are you an adult with ADHD who has been taking medication for the past 6 months? You may be eligible to participate in a research study for an FDA approved medication.
Elite Clinical Trials, Inc.
Are you an adult with ADHD who has been taking medication for the past 6 months? You may be eligible to participate in a research study for an FDA approved medication.
Elite Clinical Trials, Inc.
Are you suffering from ADD/ADHD Symptoms? (Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder)
View More »
Pharmacology Research Institute
Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder
Collaborative Neuroscience Network Inc
Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder
Bernardo Ng
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
University of California at Irvine
Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder
Pharmacology Research Institute
Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder
UCLA
Patients are needed to participate in a clinical research study evaluating EMS 7500 Digital Muscle Stimulator for the treatment of Attention-Deficit/Hyperactivity Disorder
Synergy Clinical Research Center
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Synergy Clinical Research Center
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Pharmacology Research Institute
Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder
Pacific Sleep Medicine, A Medical Corporation
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Excell Research, Inc
Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder
Neuropsychiatric Research Center for Orange County
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
SDS Clinical Trials, Inc.
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Pacific Clinical Research Medical Group
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Peninsula Research Associates
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Peninsula Research Associates, Inc.
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
PCSD - Feighner Research
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
PCSD - Feighner Research
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
University of California, San Francisco
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
University of California, San Francisco
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Neuropsychiatric Research Center of Orange County
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Neuropsychiatric Research Center of Orange County
Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder
Robert Lipetz, DO
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Center for Healing the Human Spirit
A clinical trial seeking patients for a research study for the treatment of Attention Deficit/Hyperactivity Disorder
Eliot Moon, MD
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Elite Clinical Trials
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Colorado
IMMUNOe International Research Center
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
MCB Clinical Research Centers, LLC
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
MCB Clinical Research Centers, LLC
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Connecticut
Coastal Connecticut Research, LLC
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Florida
View More »
Florida Clinical Research Center, LLC
Updated
A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder
Florida Clinical Research Center, LLC
A clinical trial seeking patients for a research study for the treatment of ADHD
Florida Clinical Research Center
A Phase 3 clinical study for patients with Attention Deficit Hyperactivity Disorder (ADHD)
Florida Clinical Research Center, LLC
Updated
A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder
Florida Clinical Research Center, LLC
Patients are needed to participate in a clinical research study evaluating TD-9855 and Placebo for the treatment of Attention-Deficit/Hyperactivity Disorder or ADHD
Florida Clinical Research Center, LLC
Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder
First 1 2 3 4 5 6 Last
